We Have A Strategic Vision for Global Aging

Taking On Longevity with Market Innovation

We develop initiatives that focus on meeting the challenges of worldwide aging with groundbreaking market solutions and progressive public policies.

Through our white papers, roundtables, webinars, presentations to third parties, and other communications materials, we are leading the global aging dialogue and providing public education designed to enable healthier and more active aging.

Reckoning With the Rare Disease Landscape: Reframing Rare Diseases as a Strategic Priority for Healthy Aging and Health System Sustainability

Rare diseases affect an estimated 300 million people worldwide. More than a quarter of people living with a rare disease are diagnosed in adulthood, and the 60-plus population most likely to be affected is set to nearly double by 2050. Most diagnostic and reimbursement systems, however, remain built around pediatric cases. Reckoning With the Rare Disease Landscape, a new report from the Global Coalition on Aging (GCOA) and the Global Rare Disease Policy Network (GRDPN), looks at different methods of addressing rare disease at the intersection of innovation, equity, and population aging.

Read Now

Travel for Healthy Longevity: Health and Economic Benefits of Multigenerational Travel

A new report from the Global Coalition on Aging and Transamerica Institute, examines the rise of silver tourism (age 55+) and multigenerational travel as a driver of healthy aging, family connection, and economic growth.

Read Now

Publishing & The Silver Economy

More than 60% of Rakuten Kobo's customers are over 55. That's not an anomaly, it's a signal. In April 2026, GCOA and Rakuten Kobo convened senior leaders from across publishing, media, and aging advocacy for a private executive roundtable in New York to unpack what that means for every consumer-facing industry.

Read Now

Infographic on Adult Immunization for Healthy Workforces and Healthy Economies in an Aging World

In June 2026, GCOA and the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) released this infographic outlining the economic and workforce case for adult immunization in an aging world.

Read Now

Travel and Healthy Aging: Part I

2013

→

Aegon Retirement Readiness Survey

2013

→

Aegon Retirement Readiness Survey – Younger Workers

2013

→

Adult Vaccines Report

2013

→

Expert Consultation on Alzheimer’s and Big Data

2013

→

Aegon Retirement Readiness Survey

2012

→

IFA 11th Global Conference on Ageing

2012

→

Educational Attainment and Retirement Report

2010

→

Claim your seat at the table